Significant milestone toward the commercialization of eptinezumab, the first quarterly infusion therapy for migraine prevention.
from "updates on food" - Google News https://ift.tt/2Ix4ygW
Saturday, 23 February 2019
Alder BioPharmaceuticals® Submits Biologics License Application to the U.S. Food and Drug Administration for Eptinezumab - GlobeNewswire
Alder BioPharmaceuticals® Submits Biologics License Application to the U.S. Food and Drug Administration for Eptinezumab GlobeNewswire
from "updates on food" - Google News https://ift.tt/2Ix4ygW
from "updates on food" - Google News https://ift.tt/2Ix4ygW
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment